The DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases
Open accessAbstract
Importance: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standing observations of an association between immune-mediated diseases and Parkinson disease (PD). The post-GWAS era provides an opportunity for cross-phenotype analyses between different complex phenotypes. Objectives: To test the hypothesis that there are common genetic risk variants conveying risk of both PD and autoimmune diseases (ie, pleiotropy) and to identify new shared genetic variants and their pathways by applying a novel statistical framework in a genome-wide approach. Design, Setting, and Participants: Using the conjunction false discovery rate method, this study analyzed GWAS data from a selection of archetypal autoimmune diseases among 138 511 individuals of European ancestry and systemically investigated pleiotropy between PD and type 1 diabetes, Crohn disease, ulcerative colitis, rheumatoid arthritis, celiac disease, psoriasis, and multiple sclerosis. NeuroX data (6927 PD cases and 6108 controls) were used for replication. The study investigated the biological correlation between the top loci through protein-protein interaction and changes in the gene expression and methylation levels. The dates of the analysis were June 10, 2015, to March 4, 2017. Main Outcomes and Measures: The primary outcome was a list of novel loci and their pathways involved in PD and autoimmune diseases. Results: Genome-wide conjunctional analysis identified 17 novel loci at false discovery rate less than 0.05 with overlap between PD and autoimmune diseases, including known PD loci adjacent to GAK, HLA-DRB5, LRRK2, and MAPT for rheumatoid arthritis, ulcerative colitis and Crohn disease. Replication confirmed the involvement of HLA, LRRK2, MAPT, TRIM10, and SETD1A in PD. Among the novel genes discovered, WNT3, KANSL1, CRHR1, BOLA2, and GUCY1A3 are within a protein-protein interaction network with known PD genes. A subset of novel loci was significantly associated with changes in methylation or expression levels of adjacent genes. Conclusions and Relevance: The study findings provide novel mechanistic insights into PD and autoimmune diseases and identify a common genetic pathway between these phenotypes. The results may have implications for future therapeutic trials involving anti-inflammatory agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Multiple common genetic variants between PD patients and other inflammatory diseases have been identified.249,250”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [249]
The cited source says what the claim attributes to it.
In the citing paper
“Genomewide association studies have alluded to a significant genetic overlap between Parkinson's disease and autoimmune diseases.97”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,088
Self-citationGenome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Self-citationInternational Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citation
Flagged first, then by citations
2 of the 84 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [16]16. Nielsen NM, Pasternak B, Stenager E, Koch-Henriksen N, Frisch M. Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study. Eur J Neurol. 2014;21(1):107-111. Medline:24053187
Cited by
Sorted by citations
Items 201–300 of 356
Zhou, M., Guo, R., Wang, Y., Yang, W., Li, R., & Lu, L. (2021) · BioMed Research International · doi:10.1155/2021/9957569 · Cited by 10
Self-citationPhenotypic and Genetic Links between Body Fat Measurements and Primary Open-Angle Glaucoma
Rong, S. S., & Yu, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043925 · Cited by 11
Zong, Y., Yang, Y., Zhao, J., Li, L., Luo, D., Hu, J., Gao, Y., Xie, X., Shen, L., Chen, S., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108511 · Cited by 13
Wei, R., Rong, C., Xie, Q., Wu, S., Feng, Y., Wang, R., Dai, Z., & Lin, T. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2529641 · Cited by 11
Yuan, W., Luo, Q., & Wu, N. (2024) · BMC Genomics · doi:10.1186/s12864-024-10787-0 · Cited by 10
Gorecki, A. M., Anyaegbu, C. C., Fitzgerald, M., Fuller, K. A., & Anderton, R. S. (2024) · Methods · doi:10.1016/j.ymeth.2024.10.009 · Cited by 11
Psoriasis and neurodegenerative diseases—a review
Nowowiejska, J., Baran, A. M., & Flisiak, I. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.917751 · Cited by 10
Retrotransposon insertions associated with risk of neurologic and psychiatric diseases
Ahn, H. W., Worman, Z., Lechsinska, A., Payer, L. M., Wang, T., Malik, N., Li, W., Burns, K. H., Nath, A., & Levin, H. L. (2022) · EMBO Reports · doi:10.15252/embr.202255197 · Cited by 10
Association of immune cell traits with Parkinson’s disease: a Mendelian randomization study
Song, Z., Li, W., Han, Y., Xu, Y., Ding, H., & Wang, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1340110 · Cited by 10
Self-citationMai, A. S., Tan, B. J., Sun, Q.-Y., & Tan, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020561 · Cited by 8
Wang, B., Bai, X., Yang, Y., & Yang, H. B. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06045-2 · Cited by 9
Huang, Z., & Yuan, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1468457 · Cited by 9
Grech, V.-S., Lotsaris, K., Kefala, V., & Rallis, E. A. (2025) · Genes · doi:10.3390/genes16121463 · Cited by 9
Cerantola, S., Faggin, S., Caputi, V., Bosi, A., Banfi, D., Rambaldo, A., Porzionato, A., Liddo, R. D., De, R., Savarino, E. V., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120562 · Cited by 9
Wang, Z.-T., Initiative, A. D. N., Chen, S.-D., Xu, W., Chen, K., Wang, H.-F., Tan, C., Cui, M., Dong, Q., Tan, L., et al. (2019) · Aging · doi:10.18632/aging.102066 · Cited by 9
Wang, Q., Gu, Y., Liu, X., Wang, Q., Xie, C., & Wang, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1388226 · Cited by 8
Cheng, Y.-K., & Chiang, H.-S. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08114-w · Cited by 8
Ayerra, L., Abellanas, M. A., Vidaurre, C., Basurco, L., Tavira, A., Luquin, E., Clavero, P., Mengual, E., Collantes, M., Peñuelas, I., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.037 · Cited by 8
Recinto, S. J., Kazanova, A., Liu, L., Cordeiro, B., Premachandran, S., Bessaiah, H., Allot, A., Afanasiev, E., Mukherjee, S., Pei, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00945-w · Cited by 11
Mazaki, Y., Handa, H., Fumoto, Y., Horinouchi, T., & Onodera, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01305-y · Cited by 8
Choe, Y., Jo, M. G., Kim, B. G., Lee, S., Lee, B., Kim, S., Seong, H., Yoo, W.-S., Kim, M., Lee, D., et al. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103256 · Cited by 8
Immunogenetics of Parkinson’s Disease
Jiménez-Ferrer, I., & Swanberg, M. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch2 · Cited by 9
Parkinsonism in autoimmune diseases
Barba, C., & Alexopoulos, H. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.015 · Cited by 9
Su, W., Gu, X., Hou, Y., Zhang, L., Cao, B., Ou, R., Wu, Y., Chen, X., Song, W., Zhao, B., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.765833 · Cited by 10
Li, D., Hong, X., & Chen, T. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.885179 · Cited by 8
Disentangling the complexity of psoriasis in the post-genome-wide association era
Antonatos, C., Grafanaki, K., Georgiou, S., Evangelou, E., & Vasilopoulos, Y. (2023) · Genes and Immunity · doi:10.1038/s41435-023-00222-x · Cited by 8
Linking mitochondria to the immune response
Wallings, R. L., Herrick, M. K., & Tansey, M. G. (2020) · eLife · doi:10.7554/elife.56214 · Cited by 8
Luo, Q., An, M., Wu, Y., Wang, J., Mao, Y., Zhang, L., & Wang, C. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00551-3 · Cited by 7
Muñoz‐Delgado, L., Williams‐Gray, C. H., Garraux, G., Clemente, D., Çakmak, Ö. Ö., Greenland, J. C., Figueira, I., Machín-Díaz, I., Pirovano, E., di Flora, A., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01146-1 · Cited by 7
Hypertension as a Novel Link for Shared Heritability in Age at Menarche and Cardiometabolic Traits
Fan, H., Chien, K., Huang, Y., Hsu, J.-W., Chen, Y.-Y., Lai, E., Lu, T., Li, H., Li, H., Hsu, S., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad104 · Cited by 7
LRRK2 G2019S and Parkinson’s disease: insight from Neuroinflammation
Yao, X.-Y., Guan, L.-N., Chen, Q., & Ren, C. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad080 · Cited by 8
Wang, H., Wang, Z., Tian, J., Ma, D., & Shi, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1294879 · Cited by 7
Luo, A., Yang, Q., Zhang, Z., Yang, Y., Li, X., Deng, Y., He, L., & Zhou, M. (2024) · Joint Bone Spine · doi:10.1016/j.jbspin.2024.105793 · Cited by 7
Inflammation and IL-4 regulate Parkinson’s and Crohn’s disease associated kinase LRRK2
Dikovskaya, D., Pemberton, R., Taylor, M., Tasegian, A., Bhattacharya, P., Zeneviciute, K., Sammler, E. M., Howden, A. J. M., Alessi, D. R., & Swamy, M. (2025) · EMBO Reports · doi:10.1038/s44319-025-00473-x · Cited by 7
Fire prevention in the Parkinson’s disease brain
Brundin, L., Bergkvist, L., & Brundin, P. (2018) · Nature Medicine · doi:10.1038/s41591-018-0109-4 · Cited by 7
Emerging Targets for the Diagnosis of Parkinson’S Disease: Examination of Systemic Biomarkers
Cheslow, L., Snook, A. E., & Waldman, S. A. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0654 · Cited by 7
Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum
Zinnen, A. D., Vichich, J. M., Metzger, J. M., Gambardella, J. C., Bondarenko, V., Simmons, H. A., & Emborg, M. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269190 · Cited by 7
MhcII Regulates Transmission of α-Synuclein-Seeded Pathology in Mice
Cruz, E. G. D. L., Vo, Q., Moon, K., McFarland, K. N., Weinrich, M. J., Williams, T., Giasson, B. I., & Chakrabarty, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158175 · Cited by 7
Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease RiskPreprint
Han, Y., Teeple, E. A., Shankara, S., Sadeghi, M., Zhu, C., Liu, D., FinnGen, Wang, C., Frau, F., Klinger, K. W., et al. (2020) · medRxiv · doi:10.1101/2020.10.16.20212944 · Cited by 7
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
Bassi, M. S., Gilio, L., Galifi, G., Buttari, F., Dolcetti, E., Bruno, A., Belli, L., Modugno, N., Furlan, R., Finardi, A., et al. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106071 · Cited by 6
Hidden face of Parkinson’s disease: Is it a new autoimmune disease?
Jo, M. G., Kim, S., & Yun, S. P. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01063 · Cited by 7
Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
Aasly, J. O. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.634666 · Cited by 6
Shared Genetic Architecture between Parkinson's Disease and Brain Structural Phenotypes
Ma, D., Li, S., Shi, J., Liang, Y., Hu, Z., Hao, X., Li, M., Guo, M.-N., Zuo, C., Yu, W.-K., et al. (2023) · Movement Disorders · doi:10.1002/mds.29598 · Cited by 7
GESLM algorithm for detecting causal SNPs in GWAS with multiple phenotypes
Lyu, R., Sun, J., Xu, D., Jiang, Q., Wei, C., & Zhang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab276 · Cited by 6
Discovering New Benefits From Old Drugs With Big Data—Promise for Parkinson Disease
Olsen, A. L., Riise, T., & Scherzer, C. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0345 · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
PLEKHM1 Overexpression Impairs Autophagy and Exacerbates Neurodegeneration in rAAV-α-Synuclein Mice
Höfs, L., Geißler-Lösch, D., & Falkenburger, B. H. (2025) · Cells · doi:10.3390/cells14171340 · Cited by 5
HLA-DRB5 promotes immune thrombocytopenia via activating CD8+ T cells
Ye, Q., Ying, Q., Chen, Y., Liao, C., & Li, A. (2024) · Open Medicine · doi:10.1515/med-2024-0955 · Cited by 5
Multiple Sclerosis Biomarker Candidates Revealed by Cell-Type-Specific Interactome Analysis
Yurduseven, K., Babal, Y. K., Çelik, E., Kerman, B. E., & Kurnaz, I. A. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0023 · Cited by 5
Li, X., Luo, M., Xu, H., Jia, L., Liang, Y., Xu, Q., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1377409 · Cited by 5
Self-citationGenetics of A lzheimer's Disease
Brookes, K. J., & Morgan, K. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0020228.pub2 · Cited by 6
Adaptive Immunity and Parkinson's DiseasePreprint
Elyaman, W. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041639 · Cited by 5
Chai, Z., Ouyang, Y., Debebe, A., Picker, M., Lee, W., Fenton, S., Becker, A., Augustin-Emmerichs, K., Schwiertz, A., Weber, S. N., et al. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251328567 · Cited by 6
Gorecki, A. M., Spencer, H. L., Meloni, B. P., & Anderton, R. S. (2023) · Biomedicines · doi:10.3390/biomedicines11082089 · Cited by 4
Risk of Parkinson's Disease in Celiac Disease: A Swedish Population‐Based Study
Kang, X., Ploner, A., Roelstraete, B., Ludvigsson, J. F., & Wirdefeldt, K. (2023) · Annals of Neurology · doi:10.1002/ana.26780 · Cited by 4
Role of epigenetic modifications and aging in inflammatory bowel disease
Du, Y., Li, G., Zhou, Y., Zuo, M., Wang, H., Liu, Y., & Hong, L. (2023) · MedComm – Future Medicine · doi:10.1002/mef2.63 · Cited by 5
LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping
Lashgari, N., Roudsari, N. M., Niknejad, A., Shamsnia, H. S., Shayan, M., Shalmani, L. M., Momtaz, S., Rezaei, N., & Abdolghaffari, A. H. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273270874231205050727 · Cited by 4
Pang, T., Ding, N., Zhao, Y., Zhao, J., Yang, L., & Chang, S. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110988 · Cited by 4
Asah, C., Frandsen, R. A. V., Ibsen, R., Kjellberg, J., & Jennum, P. (2021) · Neuroepidemiology · doi:10.1159/000514175 · Cited by 4
Khish, N. S., Ghiasizadeh, P., rasti, A., Moghimi, O., Zadeh, A. Z., Bahiraee, A., & Ebrahimi, R. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230817102135 · Cited by 4
Myasthenia gravis concurrent with Parkinson’s disease in a Spanish cohort. Causation or correlation?
Gámez, J., Carmona, F., Lorenzo‐Bosquet, C., Cuberas‐Borrós, G., de Fàbregues, O., & Gamez, A. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07349-3 · Cited by 4
Chang, S., & Luo, Q. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02047-3 · Cited by 3
Chen, Y., Wang, K., Zhang, X., Yang, F., Liu, T., Cheng, A., Guan, Y., Zhong, J., Meng, J., Zhang, X., et al. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2584751 · Cited by 3
Sharallah, O. A., Malakar, V. K., Salama, A. E., Elmaaz, S. M., Daba, S. A., & Poddar, N. K. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01702-0 · Cited by 3
Associations of digestive diseases exposure and lifestyle factors with Parkinson’s disease
Yang, K., Zeng, R., Zheng, Y., Zhong, S., Wang, J., Yu, X., Zhong, H., Chen, X., Shi, Y., Lin, F., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01098-6 · Cited by 3
Parkinson Disease and Autoimmune Disorders—What Can We Learn From Genome-wide Pleiotropy?
McFarland, N. R., McFarland, K. N., & Golde, T. E. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0843 · Cited by 3
Artificial intelligence and omics-based autoantibody profiling in dementia
Matsuda, K. M., Umeda‐Kameyama, Y., Iwadoh, K., Miyawaki, M., Yakabe, M., Ishii, M., Ogawa, S., Akishita, M., Sato, S., & Yoshizaki, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1537659 · Cited by 3
Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease
Annesley, S., Allan, C., Sanislav, O., Evans, A., & Fisher, P. (2022) · Proteomes · doi:10.3390/proteomes10020020 · Cited by 4
Leucine rich repeat kinase 2 ( LRRK2 ) peptide modulators: Recent advances and future directions
Helton, L. G., Rideout, H. J., Herberg, F. W., & Kennedy, E. J. (2021) · Peptide Science · doi:10.1002/pep2.24251 · Cited by 2
Silva, J. F. (2024) · American Journal of Translational Research · doi:10.62347/owyy4960 · Cited by 2
He, Y., Wang, J., Ying, C., Liang, W., Yin, Z., Gao, J., Wang, B., Zhao, X., & Zhang, Y. (2025) · Medicine · doi:10.1097/md.0000000000044392 · Cited by 2
Immunology and microbiome: Implications for motor systems
Mahjoub, Y., & Martino, D. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00001-7 · Cited by 2
Wang, C., & Yuan, C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04691-1 · Cited by 3
COVID-19 infection and longevity: an observational and mendelian randomization study
Qiu, S., Liu, J., Guo, J., Zhang, Z., Guo, Y. L., & Hu, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05932-y · Cited by 2
Genetic overlap between Parkinson disease and inflammatory bowel diseasePreprint
Kang, X., Ploner, A., Wang, Y., Ludvigsson, J. F., Williams, D. M., Pedersen, N. L., & Wirdefeldt, K. (2022) · medRxiv · doi:10.1101/2022.01.13.22269221 · Cited by 2
Self-citationDiabetes mellitus and neurodegenerative disorders
Amin, S. N., Albakri, K. A., Alabdallat, Y. J., & Elberry, D. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00009-9 · Cited by 1
Chen, G., Luo, Q., Wu, C., & Xie, M. (2025) · Clinical Genetics · doi:10.1111/cge.14749 · Cited by 1
Qin, M., Liu, X., Luo, Q., & Cai, R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336775 · Cited by 1
Reinventing brain immunity in neurodegeneration
Huang, H., Han, Y., Han, Z., Yang, H., Fu, Y., & Liu, Q. (2025) · Immunity & Inflammation · doi:10.1007/s44466-025-00011-3 · Cited by 1
Cell-based immunotherapy for neurodegenerative disease: A promising avenue
Huerta, T. J., Urbina-Muñoz, V., Urra-Alvarez, V., Villablanca, C., Gómez‐Pérez, L. S., Saavedra, B., Contreras, T., & Vidal, R. L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00816 · Cited by 1
Beilina, A. G., Park, J.-H., Landeck, N., Chia, R., Ding, J., Reed, X., Bailey, H. M., Kim, C., Kaganovich, A., Acri, D. J., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00938-0 · Cited by 2
Self-citationSubtype-specific secretion of extracellular vesicles by LRRK2 and Rab GTPases under lysosomal stress
Sakurai, M., Kuwahara, T., Suenaga, S., Takatori, S., Tomita, T., Shalit, T., Tengstrand, E., Hsieh, F., & Iwatsubo, T. (2026) · iScience · doi:10.1016/j.isci.2026.117203 · Cited by 1
Parkinson’s disease and inflammatory bowel disease: exploring the connection between the two
Zhou, X., Zhang, X., Liang, H., & Bi, Y. (2026) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2026.01 · Cited by 1
Sun, Y., Bai, Z., & Wang, Z. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.108018 · Cited by 1
Immune response during idiopathic Parkinson's disease: From humans to animal models
Nissen, S. K., Ferreira, S. A., Klæstrup, I. H., & Romero‐Ramos, M. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.006 · Cited by 1
Characteristics of jaundice and cholestasis in a Finnish population.
Pasanen, P., Partanen, K. P. L., Pikkarainen, P. H., & ALHAVA, E. M. (1992) · PubMed · Cited by 1
Lona‐Durazo, F., Reynolds, R. H., Scholz, S. W., Ryten, M., & Taliun, S. A. G. (2022) · medRxiv · doi:10.1101/2022.12.07.22283179 · Cited by 1
Matsuda, K. M., Umeda‐Kameyama, Y., Iwadoh, K., Miyawaki, M., Yakabe, M., Ishii, M., Ogawa, S., Akishita, M., Sato, S., & Yoshizaki, A. (2024) · medRxiv · doi:10.1101/2024.09.20.24313547 · Cited by 1
Hu, Y., She, B., Yin, Z., Yu, X., Wu, W., & Chen, M. (2025) · medRxiv · doi:10.1101/2025.10.01.25337087 · Cited by 1
Bäckström, D. C. (2019) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Shadrin, A. A., Mucha, S., Ellinghaus, D., Makarious, M. B., Blauwendraat, C., Sreelatha, A. A. K., Heras‐Garvin, A., Ding, J., Hammer, M. B., Foubert‐Samier, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/751354
Self-citationPublic Relations Management Strategy for the Kalamazoo Institute of Arts
Locke, S. K. (1997)
Pullman, M. Y., Lewis, S. K., Brannagan, T. H., & Saunders-Pullman, R. J. (2021) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0000000000000348
Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
Kamel, W. A., Ismail, I. I., Ibrahim, M., & Al-Hashel, J. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00380-7
Loss of Rab8a in B cells leads to increased antibody responses and class-switch recombinationPreprint
Hernández‐Pérez, S., Sarapulov, A. V., Balcı, M. Ö., Coffey, E. T., Harada, A., & Mattila, P. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.19.508414
Brockmann, K., Lerche, S., Zimmermann, M., Röeben, B., Wurster, I., Fries, F. L., Deuschle, C., Waniek, K., Lachmann, I., Jakobi, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2131597/v1
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00018-6
Identification of Shared Pathogenetic Genes in Parkinson’s Disease and Type 2 DiabetesPreprint
Chen, L., Wang, Y., Hu, B., Huang, J., & Huang, W. (2023) · Research Square · doi:10.21203/rs.3.rs-3166035/v1
Self-citationYang, H. J., Lee, M. Y., Lee, J. H., Jung, C. J., Lee, W. J., Won, C. H., Lee, M. W., Jung, J. M., & Chang, S. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-54407-z
Alarcón‐Romero, L. D. C., Zubillaga‐Guerrero, M. I., William, C. I. M., Illades‐Aguiar, B., García, A. M. E., Rivera, M. J. M., Barrera, J. A. P., Gómez‐Gómez, Y., & Hernández, M. V. (2024) · doi:10.22533/at.ed.8022401044
Metadata
- Authors
- Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., Bettella, F., Ellinghaus, D., Franke, A., Lie, B. A., McEvoy, L. K., Karlsen, T. H., Lesage, S., Morris, H. R., Brice, A., Wood, N. W., Heutink, P., Hardy, J., Singleton, A. B., Dale, A. M., Gasser, T., Andreassen, O. A., Sharma, M., & for the International Parkinson’s Disease Genomics Consortium (IPDGC), N. A. B. E. C. (.
- Affiliations
- Oslo University Hospital (NO)
- German Center for Neurodegenerative Diseases (DE)
- University of Oslo (NO)
- University of California, San Francisco (US)
- National Institutes of Health (US)
- University of Copenhagen (DK)
- University of California San Diego (US)
- Christian-Albrechts-Universität zu Kiel (DE)
- Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany
- Centre National de la Recherche Scientifique (FR)
- National Hospital for Neurology and Neurosurgery (GB)
- UCL Queen Square Institute of Neurology (GB)
- University College London (GB)
- Hertie Institute for Clinical Brain Research (DE)
- Corresponding author
- Sharma, Manu
- ORCID
- Witoelar, Aree
- Jansen, Iris E.
- Wang, Yunpeng
- Desikan, Rahul S.
- Gibbs, J. Raphael
- Blauwendraat, Cornelis
- Thompson, Wesley K.
- Hernandez, Dena G.
- Djurovic, Srdjan
- Schork, Andrew J.
- Bettella, Francesco
- Ellinghaus, David
- Lie, Benedicte A.
- McEvoy, Linda K.
- Karlsen, Tom H.
- Lesage, Suzanne
- Morris, Huw R.
- Brice, Alexis
- Wood, Nicholas W.
- Heutink, Peter
- Hardy, John
- Singleton, Andrew B.
- Dale, Anders M.
- Gasser, Thomas
- Andreassen, Ole A.
- Sharma, Manu
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-07-01
- Volume
- 74
- Issue
- 7
- Pages
- 780
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5710535
- OpenAlex
- W2622719965
- Semantic Scholar
- 77f8aa61d1d32875fc37fcce3fe356cd20cd596e
- Cited by
- 352
- References
- 84
- Citations by year
- 2026: 14 · 2025: 39 · 2024: 60 · 2023: 41 · 2022: 39 · 2021: 62 · 2020: 34 · 2019: 30 · 2018: 24 · 2017: 7
- FWCI
- 18.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Biogen
- Washington University in St. Louis
- Johns Hopkins University
- University of Rochester
- Wellcome Trust
- Sandwell and West Birmingham Hospitals NHS Trust
- University Hospitals Birmingham NHS Foundation Trust
- Université de Lille
- Parkinson's UK (G-0907, J-0901, J-1402, K-1501)
- Imperial College London
- University College London
- University of Oxford
- Newcastle University
- Cardiff University
- University of Aberdeen
- Institut National de la Santé et de la Recherche Médicale
- Universiteit Leiden
- Universiteit van Amsterdam
- Radboud Universiteit
- Vrije Universiteit Amsterdam
- Eberhard Karls Universität Tübingen
- Centre National de la Recherche Scientifique
- Leids Universitair Medisch Centrum
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Université Pierre et Marie Curie
- National Institutes of Health
- Genentech
- Medical Research Council
- Erasmus Universitair Medisch Centrum Rotterdam
- Helmholtz Zentrum München
- National Human Genome Research Institute
- National Institute of General Medical Sciences (R01GM104400)
- National Institute of Neurological Disorders and Stroke
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- Parkinson's disease, autoimmune disease, pleiotropy, type 1 diabetes, Crohn's disease, ulcerative colitis, rheumatoid arthritis, celiac disease, psoriasis, multiple sclerosis, LRRK2, HLA, MAPT, SETD1A, protein-protein interaction network, DNA methylation, gene expression, anti-inflammatory therapy
- MeSH terms
- Arthritis, Rheumatoid, Autoimmune Diseases, Celiac Disease, Colitis, Ulcerative, Crohn Disease, Diabetes Mellitus, Type 1, Humans, Multiple Sclerosis, Parkinson Disease, Psoriasis, Risk Factors, Genetic Predisposition to Disease, Genome-Wide Association Study, Genetic Loci, Genetic Pleiotropy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
